Northern Trust Corp Immunovant, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Immunovant, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 506,990 shares of IMVT stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

506,990

Previous 463,721 9.33%

Holding current value

$13.9 Million

Previous $12.2 Million 13.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.51 - $27.51 $1.19 Million - $1.19 Million	43,269 Added 9.33%	506,990 $13.9 Million
Q2 2024 Aug 14, 2024	SELL	$25.1 - $31.61 $376,148 - $473,707	-14,986 Reduced 3.13%	463,721 $12.2 Million
Q1 2024 May 14, 2024	SELL	$30.27 - $43.79 $483,926 - $700,070	-15,987 Reduced 3.23%	478,707 $15.5 Million
Q4 2023 Feb 13, 2024	BUY	$31.31 - $44.19 $479,857 - $677,255	15,326 Added 3.2%	494,694 $20.8 Million
Q3 2023 Nov 13, 2023	SELL	$18.55 - $39.96 $250,276 - $539,140	-13,492 Reduced 2.74%	479,368 $18.4 Million
Q2 2023 Aug 11, 2023	BUY	$14.2 - $23.75 $1.16 Million - $1.94 Million	81,813 Added 19.9%	492,860 $9.35 Million
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $105,301 - $135,989	-6,896 Reduced 1.65%	411,047 $6.38 Million
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $448,568 - $1.21 Million	68,068 Added 19.45%	417,943 $7.42 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $28,948 - $46,921	-7,366 Reduced 2.06%	349,875 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$3.38 - $5.65 $38,008 - $63,534	-11,245 Reduced 3.05%	357,241 $1.39 Million
Q1 2022 May 13, 2022	SELL	$5.06 - $8.77 $105,804 - $183,380	-20,910 Reduced 5.37%	368,486 $2.03 Million
Q4 2021 Feb 08, 2022	SELL	$7.33 - $9.32 $12,087 - $15,368	-1,649 Reduced 0.42%	389,396 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $184,117 - $298,633	-26,265 Reduced 6.29%	391,045 $3.4 Million
Q2 2021 Aug 13, 2021	SELL	$9.4 - $16.85 $304,005 - $544,945	-32,341 Reduced 7.19%	417,310 $4.41 Million
Q1 2021 May 12, 2021	SELL	$13.08 - $49.6 $224,805 - $852,475	-17,187 Reduced 3.68%	449,651 $7.21 Million
Q4 2020 Feb 11, 2021	BUY	$36.36 - $52.71 $1.37 Million - $1.99 Million	37,807 Added 8.81%	466,838 $21.6 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $3.52 Million - $6.06 Million	155,699 Added 56.96%	429,031 $15.1 Million
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $3.49 Million - $7.16 Million	251,701 Added 1163.61%	273,332 $6.66 Million
Q1 2020 May 14, 2020	SELL	$8.36 - $17.13 $16,243 - $33,283	-1,943 Reduced 8.24%	21,631 $337,000
Q4 2019 Feb 14, 2020	BUY	$10.02 - $16.4 $236,211 - $386,613	23,574 New	23,574 $374,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Immunovant, Inc. Transaction History